Form D · Other Health Care
Envisium Health, Inc.
Framingham, MA · CIK 0001743335
Offering snapshot reported Jun 11, 2018 · SEC filing
- Reported sold
- $810K Offering amount: $810K
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 5, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2018 | Initial | $810,000 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-314328
Source: Form D, filed Jun 11, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James T. Kim | Director, Executive |
| Seunghee Lee | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
254 Cochituate Road
Framingham, MA, 01701
Framingham, MA, 01701